Immunology and Microbiology
Adenoviridae
8%
Adoptive Immunotherapy
9%
Alemtuzumab
5%
Allogeneic Bone Marrow Transplantation
7%
Allogeneic Hematopoietic Stem Cell Transplantation
8%
Antigen Specificity
5%
Antineoplastic Activity
13%
B Cell
18%
Bone Marrow Transplantation
25%
Caspase
6%
CD19
9%
CD40 Ligand
8%
CD5
5%
Chimera
5%
Chimeric Antigen Receptor
24%
Chimeric Antigen Receptor T-Cell
24%
Conditioning
8%
Cytokine
15%
Cytomegalovirus
13%
Cytotoxic T Cell
44%
Cytotoxicity
8%
Dendritic Cell
6%
Effector Cell
5%
Epstein Barr Virus
47%
Gene Transfer
13%
Graft-Versus-Host Disease
11%
Hematopoietic Cell
11%
Hematopoietic Stem Cell Transplantation
17%
Immune Reconstitution
5%
Immune Response
6%
Immune System
7%
Immunity
9%
Immunotherapy
15%
Interleukin 2
20%
Leukemia Cell
5%
Lymphoblastoid Cell Line
5%
Lymphocyte
6%
Monoclonal Antibody
7%
Myeloid
15%
Regulatory T Cell
5%
Retrovirus Vector
6%
Stem Cell
13%
Stem Cell Transplantation
10%
T Cell
100%
T Cell Receptor
12%
Transgenics
10%
Tumor Antigen
12%
Tumor Cell
10%
Viral Disease
10%
Virus
17%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
8%
Acute Myeloid Leukemia
8%
Adenoviridae
6%
Allogeneic Hematopoietic Stem Cell Transplantation
5%
Allogenic Bone Marrow Transplantation
7%
Antineoplastic Activity
7%
Autologous Bone Marrow Transplantation
11%
B Cell
14%
B-Cell Chronic Lymphocytic Leukemia
5%
Bone Marrow Transplantation
11%
Cancer
25%
Cancer Growth Factor
6%
Caspase 9
5%
Cell Therapy
23%
Chimeric Antigen Receptor
21%
Chimeric Antigen Receptor T-Cell
26%
Chimeric Antigen Receptor T-Cell Immunotherapy
5%
Cytokine
6%
Cytotoxic T-Cell
27%
Diseases
17%
Epstein Barr Virus
26%
Ganglioneuroblastoma
6%
Gene Therapy
8%
Gene Transfer
7%
Graft Versus Host Reaction
8%
Hematologic Malignancy
11%
Hematopoietic Cell
6%
Hematopoietic Stem Cell Transplantation
11%
Hodgkin's Lymphoma
8%
Immune Response
7%
Immunity
5%
Immunotherapy
13%
In Vitro
8%
Infusion
15%
Interleukin 2
11%
Leukemia
10%
Lymphoproliferative Disease
8%
Malignant Neoplasm
10%
Marker Gene
8%
Neoplasm
26%
Pediatrics
7%
Receptor
5%
Solid Malignant Neoplasm
7%
Stem Cell Therapy
7%
T Cell
79%
T Lymphocyte
9%
Transplantation
11%
Tumor Antigen
8%
Tumor Cell
10%
Virus
9%
Keyphrases
Adoptive Cell Therapy
8%
Allogeneic Bone Marrow Transplantation
9%
Antitumor Activity
7%
Bone Marrow Transplantation
11%
Chimeric Antigen Receptor T Cells (CAR-T)
11%
Cytotoxic T Lymphocytes
5%
Epstein-Barr Virus
12%
Gene Transfer
11%
Graft-versus-host Disease (GvHD)
5%
Hematological Malignancies
9%
Immune Response
5%
Leukemia
8%
Lymphoma
10%
Malignancy
5%
Marrow
7%
T Cells
20%
Tumor
7%
Tumor Cells
7%